Hypera SA
Change company Symbol lookup
Select an option...
HYPMY Hypera SA
WILC G Willi-Food International Ltd
WTBA West Bancorporation Inc
RGSEQ Real Goods Solar Inc
CVI CVR Energy Inc
OSTK Overstock.com Inc
EGIL Edgetech International Inc
XOM Exxon Mobil Corp
AIV Apartment Investment and Management Co
VTI Vanguard Total Stock Market Index Fund ETF Shares
Go

Health Care : Pharmaceuticals | Mid Cap Blend
Based in Brazil
Company profile

Hypera SA, formerly Hypermarcas SA, is a Brazil-based company engaged in the pharmaceuticals sector. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. The Branded Prescription unit also acts as Mantecorp Skincare in dermocosmetics, with products recommended by dermatologists. Consumer Health offers non-prescription drugs, with brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. The Consumer Health unit also operates in nutritionals and vitamin supplements, with brands such as Tamarine, Vitasay, Biotonico Fontoura and Zero-Cal. Branded Generics operates under the Neo Quimica brand.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$6.73
Day's Change
-0.31 (-4.40%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.03
Day's Low
6.73
Volume
(Light)
Volume:
5,315

10-day average volume:
9,492
5,315

UPDATE: ContextLogic stock rises as revenue tops Street view

4:21 pm ET March 8, 2021 (MarketWatch)
Print

ContextLogic Inc. shares rose in the extended session Monday after the parent company of mobile e-commerce platform Wish reported revenue and a forecast above Wall Street expectations in the company's first quarterly results since going public. ContextLogic shares rose about 7% after hours, following a 10% drop in the regular session to close at $15.94. The company reported a fourth-quarter loss of $569 million, or $3.04 a share, compared with a loss of $124 million, or $1.20 a share, in the year-ago period. Revenue rose to $794 million from $576 million in the year-ago quarter. Analysts surveyed by FactSet had forecast a loss of $2.27 a share on revenue of $736.1 million. ContextLogic forecast revenue of $735 million to $750 million for the first quarter, while analysts had estimated revenue of $669.2 million. ContextLogic's stock went public in mid-December (https://www.marketwatch.com/story/wishs-stock-open-below-ipo-price-2020-12-16), pricing at $24 a share.

-Wallace Witkowski; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

March 08, 2021 16:21 ET (21:21 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.